Found 89 matching trials
CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon) PHASE3 This study is a Phase III non-inferiority trial targeting a specific subset...
Show More Location
Multiple Locations
Learn More & Join Trial
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer PHASE2 This study is a prospective, open-label, randomized, multicenter, two-cohor...
Show More Location
The Second Affiliated Hospital of Dalian Medical University
Learn More & Join Trial
Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy PHASE2 This study aimed to evaluate the efficacy and safety of Dalpiciclib combine...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients PHASE2 A multicenter, prospective, open, randomized cohort, non controlled phase I...
Show More Learn More & Join Trial
Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer PHASE2 In this single arm, open label, phase 2 trial, operable patients with stage...
Show More Location
Yantai Yuhuangding Hospital
Learn More & Join Trial
Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower) PHASE2 This study is a prospective, single-arm, phase II clinical study for patien...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer PHASE3 This study is a prospective, open-label, multicenter, randomized controlled...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer N/A This study is a multi-center, observational, real-world study. We planned t...
Show More Location
The Fourth hospital of Hebei University
Learn More & Join Trial
A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy. PHASE3 The study is being conducted to evaluate the efficacy and safety of HRS-808...
Show More Location
Chinese PLA General Hospital Fifth Medical Center
Learn More & Join Trial
An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer PHASE4 This is a single-arm, open-label, exploratory clinical study...
Location
Multiple Locations
Learn More & Join Trial